vimarsana.com

Latest Breaking News On - Reports final data - Page 1 : vimarsana.com

Relief Therapeutics Wholly Owned Subsidiary, APR Applied Pharma Research, Reports Final Data from Its Clinical Trial of Novel Nasal Spray, Sentinox, in SARS-CoV-2 Infected Patients

Relief Therapeutics Holding SA / Key word(s): Study results Relief Therapeutics Wholly Owned Subsidiary, APR Applied Pharma Research, Reports.

Giancarlo icardiMichael millerJack weinsteinAdvita lifescience gmbRelief therapeutics holdingPharma researchNeurorx incSwiss exchangeRx communications groupRelief therapeutic wholly owned subsidiaryReports final dataIts clinical trialNovel nasal sprayPrimary endpointBeing metSmall sample size

EQS-Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Wholly Owned Subsidiary, APR Applied Pharma Research, Reports Final Data from Its Clinical Trial of Novel Nasal Spray, Sentinox, in SARS-CoV-2 Infected Patients

Relief Therapeutics Holding SA / Key word(s): Study results Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Reports Final Data from Its Clinical Trial of Novel Nasal Spray

Switzerland generalGiancarlo icardiMichael millerJack weinsteinAdvita lifescience gmbRelief therapeutics holding sa keyPharma researchSwiss exchangeRx communications groupRelief therapeutics holdingNews serviceNeurorx incTherapeutic wholly owned subsidiaryReports final dataIts clinical trialNovel nasal spray

vimarsana © 2020. All Rights Reserved.